A PYMNTS Company

Siemens to Acquire Dotmatics in $5.1 Billion Deal to Strengthen AI-Powered Life Sciences Portfolio

By  |  April 2, 2025
Siemens

Siemens AG announced on Wednesday its agreement to acquire U.S.-based Dotmatics for $5.1 billion from Insight Partners, marking a strategic expansion in the life sciences sector. According to Reuters, the acquisition aligns with Siemens’ broader ambitions to enhance its artificial intelligence-driven industrial software offerings.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Dotmatics provides a leading platform featuring a robust suite of scientific applications and multi-modal data management tools tailored for life sciences research and development. Per Reuters, its technologies are designed to accelerate innovation by fostering next-generation collaboration and contextualized data integration, which are essential for AI-powered multi-modal drug development.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Siemens’ President and CEO, Roland Busch, emphasized the transformative potential of artificial intelligence across industries, particularly in life sciences. “By acquiring Dotmatics, we’re strategically strengthening our position in Life Sciences and creating a world-leading AI-powered PLM software portfolio as part of Siemens Xcelerator,” Busch stated. He further highlighted that the acquisition is a key component of the company’s ONE Tech growth program, which aims to reinforce Siemens’ leadership in industrial software and enable customers to innovate more rapidly.

    Read more: Siemens Healthineers Bids Over €200 Million for Novartis’ PET Imaging Business

    According to Reuters, the financial framework for the acquisition involves funding primarily through the sale of shares in publicly traded companies, including Siemens Healthineers. Ralf P. Thomas, CFO of Siemens AG, noted the strong financial prospects of the deal. “The acquisition of Dotmatics drives strong revenue synergies and is highly profitable and cash generative,” he said.

    The acquisition reflects Siemens’ commitment to advancing AI-driven solutions within the life sciences industry. By integrating Dotmatics into its portfolio, Siemens aims to harness cutting-edge data management and software capabilities to support scientific innovation and development.

    Source: Reuters